Exploring the Potential Mechanism of Qi-Shen-Di-Huang Drug Formulary for Myasthenia Gravis (MG) based on UHPLC-QE-MS Network Pharmacology and Molecular Docking Techniques

<div>Potential targets of action of QSDH drug formulary for MG treatment PPI network. (Lighter to darker colors and smaller to larger circles represent larger target protein values, representing more important core targets).</div>

Evidence-Based Complementary and Alternative Medicine

fig5

Figure 5

Figure 5: Exploring the Potential Mechanism of Qi-Shen-Di-Huang Drug Formulary for Myasthenia Gravis (MG) based on UHPLC-QE-MS Network Pharmacology and Molecular Docking Techniques 

Figure 5 | Exploring the Potential Mechanism of Qi-Shen-Di-Huang Drug Formulary for Myasthenia Gravis (MG) based on UHPLC-QE-MS Network Pharmacology and Molecular Docking Techniques 